Effects of propylthiouracil treatment on antioxidant activities in blood of toxic multinodular goiter patients

Pharmacology

Volumn 61, Issue 1, 2000, Pages 31-36

  Özdem, Sebahat ^a   Alicigüzel, Yakup ^a   Özdem, Sadi S ^a   Karayalçin, Ümit ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Antioxidant; Hyperthyroidism; Lipid peroxidation; Propylthiouracil

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CATALASE; CERULOPLASMIN; COPPER ZINC SUPEROXIDE DISMUTASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; PROPYLTHIOURACIL; SELENIUM;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; TOXIC GOITER;

EID: 0343953570     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028377     Document Type: Article

References (38)

1. Asayama K, Dobashi K, Hayashibe H, Megata Y, Kato K: Lipid peroxidation and free radical scavengers in thyroid dysfunction in the rat: A possible mechanism of injury to heart skeletal muscle in hyperthyroidism. Endocrinology 1991;121:2112-2118.
2. Pereira B, Costa Rosa LFBP, Safi DA, Beedhara EJH, Curi R: Control of superoxide dismutase, catalase and glutathione peroxidase activities in rat lymphoid organs by thyroid hormones. J Endocrinol 1994;140:73-77.
3. Dumitriu L, Bartoc T, Ursu H, Purice M, Ionescu V: Significance of high levels of serum malonyl dialdehyde (MDA) and ceruloplasmin (CP) in hyper- and hypothyroidism. Endocrinologie 1988;26:35-38.
4. Videla LA, Sir T, Wolff C: Increased lipid peroxidation in hyperthyroid patients: Suppression by propylthiouracil treatment. Free Rad Res Commun 1988;5:1-10.
5. Hebbel RP: Erythrocyte antioxidants and membrane vulnerability. J Lab Clin Med 1986; 107:401-404.
6. Clemens MC, Waller HD: Lipid peroxidation in erythrocytes. Chem Phys Lipids 1987;45: 251-268.
7. Kurasaki M, Saito T, Kaji H, Kojima Y, Saito K: Increased erythrocyte catalase activity in patients with hyperthyroidism. Horm Metabol Res 1986;18:56-59.
8. Erkiliç AB, Ahicigüzel Y, Erkiliç M, Aksu A: Ceruloplasmin and vitamin E levels in toxic multinodular goiter. Nutr Res 1996;6:185-189.
9. Seven A, Seymen O, Hatemi S, Hatemi H, Yigit G, Candan G: Antioxidant status in experimental hyperthyroidism: Effect of vitamin E supplemenation. Clin Chim Acta 1996;256: 65-74.
10. Seven A, Tasan E, Hatemi H, Burcak G: The impact of propylthiouracil therapy on lipid peroxidation and antioxidant status parameters in hyperthyroid patients. Acta Med Okayama 1999;53:27-30.
11. Seven A, Tasan E, Inci F, Hatemi H, Burcak G: Biochemical evaluation of oxidative stress in propylthiouracil treated hyperthyroid patients: Effects of vitamin C supplementation. Clin Chem Lab Med 1998;36:767-770.
12. Seymen O, Seven A, Candan G, Yigit G, Hatemi S, Hatemi H: The effect of iron supplementation on GSH levels, GSH-Px, and SOD activities of erythrocytcs in L-thyroxine administration. Acta Med Okayama 1997;51:129-133.
13. Pearson HA, Druyan R: Erythrocyte glucose-6-phosphate dehydrogenase activity related to thyroid activity. J Lab Clin Med 1961;57:343-349.
14. Swaminathan R, Segal NH, Chapman C, Morgan DB: Red-blood-cell composition in thyroid disease. Lancet 1976;25:1382-1385.
15. Nehal M, Baquer NZ: Changes in hexokinase and glucose-6-phosphate dehydrogenase in red cells during hypo- and hyperthyroidism. Biochem Int 1989;19:193-199.
16. Saito T: Superoxide dismutase level in human erythrocytes and its clinical application to the patients with cancers and thyroidal dysfunctions. Hokkaido Igaku Zasshi 1987;62:257-268.
17. Morini P, Casalino E, Sblano C, Landriscina C: The response of rat liver lipid peroxidation, antioxidant enzyme activities and glutathione concentration to the thyroid hormone. Int J Biochem 1991;23:1025-1030.
18. Aboul-Enein HY, Al-Andis NM: Synthesis and antithyroid activity of fluorinated 2-thiouracil analogues. J Enz Inhib 1993;7:197-202.
19. Haynes Jr RC: Thyroid and antithyroid drugs; in Gilman AG, Rall TW, Nies AS, Taylor P (eds): Goodman and Gilman's the Pharmacological Basis of Therapeutics. New York, Pergamon Press, 1990, pp 1361-1383.
20. Aboul-Enein HY, Awad AA, Al-Andis NM: Synthesis and the antiperoxidase activity of seleno analogues of the antithyroid drug propylthiouracil. J Enz Inhib 1993;7:147-150.
21. Rodriguez Pierce M, Sosenko IR, Whitney P, Frank L: Propylthiouracil treatment decreases the susceptibility to oxygen radical-induced lung damage in newborn rats exposed to prolonged hyperoxia. Pediatr Res 1994;35:530-535.
22. Hicks M, Wong LS, Day RO: Antioxidant activity of propylthiouracil. Biochem Pharmacol 1992;43:439-444.
23. Faure M, Lissi EA, Videla LA: Evaluation of the antioxidant properties of thyroid hormones and propylthiouracil in the brain-homogenate autooxidation system and in the free radical-mediated oxidation of erythrocyte membranes. Chem Biol Interact 1991;77:173-185.
24. Zinkham WH: An in vitro abnormality of glutathione metabolism in erythrocytes from normal newborns: Mechanism and clinical significance. Pediatrics 1959;23:18-32.
25. Aebi H: Catalase; in Bergmeyer HU (ed): Methods of Enzymatic Analysis. Weinheim, Verlag Chemie, 1974 vol 2, pp 673-678.
26. Misra HP, Fridowich I: The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972;247:3170-3175.
27. Tietz NW: Textbook of Clinical Chemistry. Philadelphia, Saunders, 1986.
28. Paglia DE, Valentine WN: Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-169.
29. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-358.
30. Sheehan TM, Gao M: Simplified fluorometric assay of total selenium in plasma and urine. Clin Chem 1990;36:2124-2126.
31. Desai ID: Vitamin E analysis methods for animal tissues. Meth Enzymol 1984;105:138-147.
32. Schosinsky KH, Lehmann HP, Beeler MF: Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride. Clin Chem 1974;20:1556-1563.
33. Arthur JR: The role of selenium in thyroid hormone metabolism. Can J Physiol Pharmacol 1991;69:1648-1652.
34. Aihara K, Nishi Y, Hatano S, Kihara M, Yoshimitsu K, Takeichi N: Zinc, copper, manganese and selenium metabolism in thyroid disease. Am J Clin Nutr 1984;40:26-35.
35. Danis I, Marchiulenite D, Danite E, Cherniauskene R: Vitamin E and malondialdehyde in the blood serum of thyrotoxicosis patients. Rev Belge Med Dent 1990;36:21-24.
36. Ademoǧlu E, Gökkuşu C, Yarman S, Azizlerli H: The effect of methimazole on the oxidant and antioxidant system in patients with hyperthyroidism. Pharmacol Res 1998;38:93-96.
37. Wilson R, Chopra M, Bradley H, McKillop JH, Smith WE, Thomson JA: Free radicals and Graves' disease: The effects of therapy. Clin Endocrinol Oxf 1989;30:429-433.
38. Sosenko IR, Frank L: Thyroid inhibition and developmental increases in fetal rat lung antioxidant enzymes. Am J Physiol 1989;257: L94-L99.